Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Debt / NOTE 4/0
-
Market price (% of par)
-
96.68%
-
Total 13F principal
-
$561,167,910
-
Principal change
-
+$19,894,910
-
Total reported market value
-
$543,386,109
-
Number of holders
-
47
-
Value change
-
+$17,580,583
-
Number of buys
-
17
-
Number of sells
-
31
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q4 2024
As of 31 Dec 2024,
IONIS PHARMACEUTICALS INC - NOTE 4/0 was held by
47 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$561,167,910
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., Weiss Asset Management LP, Voya Investment Management LLC, CAPSTONE INVESTMENT ADVISORS, LLC, STEELHEAD PARTNERS LLC, LAZARD ASSET MANAGEMENT LLC, CSS LLC/IL, BlackRock, Inc., Calamos Advisors LLC, and HIGHBRIDGE CAPITAL MANAGEMENT LLC.
This page lists
47
institutional bondholders reporting positions
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.